In recent months it has emerged that the novel coronavirus—responsible for the COVID-19
pandemic—causes reduction of smell and taste in a large fraction of patients. The …

Despite intense research there is currently no effective vaccine available against the new
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged in the later 2019 …

Patients with coronavirus disease (COVID-19) are described as exhibiting oxygen levels
incompatible with life without dyspnea. The pairing—dubbed happy hypoxia but more …

A significant proportion of people who test positive for COVID-19 have chemosensory
deficits. However, the reported prevalence of these deficits in smell and taste varies widely …

Objective To prospectively assess the rate and timing of recovery of olfactory (OD) and
gustatory (GD) dysfunction in patients affected by COVID-19. Study Design Cohort study …

Objective The objective of this study was to determine the burden of depressed mood and
anxiety in COVID‐19, and associated disease characteristics. Materials and Methods This is …

Background: The growing number of COVID-19 patients with long-lasting olfactory disorders
makes it necessary to identify effective treatments that enhance the spontaneous recovery of …

While olfactory dysfunction associated with coronavirus disease 2019 (COVID-19) has
attracted considerable interest, few studies have tracked outcomes at serial time points or …

Background The spectrum of neurological involvement in COVID-19 is not thoroughly
understood. To the best of our knowledge, no systematic review with meta-analysis and a …

Purpose There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of
Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of …